Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,632Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 29ALCON LABS INC

02 2BAUSCH AND LOMB INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 9056057

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210565

Patent Use Code : U-2491

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 9532955

Drug Substance Claim :

Drug Product Claim :

Application Number : 210565

Patent Use Code : U-2491

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 10058511

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210565

Patent Use Code : U-2492

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 11219596

Drug Substance Claim :

Drug Product Claim :

Application Number : 210933

Patent Use Code : U-2985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 11219597

Drug Substance Claim :

Drug Product Claim :

Application Number : 210565

Patent Use Code : U-3278

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 11219597

Drug Substance Claim :

Drug Product Claim :

Application Number : 210565

Patent Use Code : U-3279

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 11596599

Drug Substance Claim :

Drug Product Claim :

Application Number : 210933

Patent Use Code : U-2985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 10857096

Drug Substance Claim :

Drug Product Claim :

Application Number : 210933

Patent Use Code : U-2985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 10864219

Drug Substance Claim :

Drug Product Claim :

Application Number : 210565

Patent Use Code : U-3011

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LOTEPREDNOL ETABONATE

US Patent Number : 10945948

Drug Substance Claim :

Drug Product Claim :

Application Number : 210933

Patent Use Code : U-2985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-03

blank